Brain cancer trial aims to outsmart tumors with adaptive radiation
NCT ID NCT04574856
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tests whether giving a higher, targeted dose of radiation to the most aggressive parts of a glioblastoma brain tumor can help people live longer. The radiation plan is adjusted during treatment based on MRI scans. The trial includes 30 adults with newly diagnosed glioblastoma who also receive the standard chemotherapy drug temozolomide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.